Effect of packed red cell and whole blood transfusion on liver-associated immune function. 1994

K Okuno, and M Ozaki, and H Shigeoka, and I Nakajima, and K Nakamura, and T Hirohata, and H Jinnai, and M Yasutomi
Department of Surgery I, Kinki University School of Medicine, Osaka-sayama, Japan.

In order to clarify the effect of allogeneic blood transfusion on liver metastases from primary cancer, liver-associated immune function after blood transfusion was evaluated in a murine model. Hepatic sinusoidal lymphocytes (HSL) were strongly cytotoxic to conventional natural killer cell-sensitive target (YAC-1), as well as to natural killer cell-resistant solid adenocarcinoma cells (colon 26), compared with splenic lymphocytes. Allogeneic whole blood transfusion strikingly suppressed the cytotoxic activities of HSL. Red blood cell transfusions also suppressed cytotoxicity to the same degree. In an animal model, allogeneic transfusion increased the rate of liver metastases. Flow cytometric analysis showed that transfusion caused a temporary decrease in the class II antigen positive cell fraction, mainly Kupffer's cells. This phenomenon occurred in parallel with changes in hepatic antitumor activity, indicating the possible importance of the involvement of Kupffer's cell in the development of the killer activity of HSL. These results suggest that blood transfusion may be a significant risk factor for hepatic metastasis by transiently suppressing the immunocompetence of the liver.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007728 Kupffer Cells Specialized phagocytic cells of the MONONUCLEAR PHAGOCYTE SYSTEM found on the luminal surface of the hepatic sinusoids. They filter bacteria and small foreign proteins out of the blood and dispose of worn out red blood cells. Kupffer Cell,Cell, Kupffer,Cells, Kupffer
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic

Related Publications

K Okuno, and M Ozaki, and H Shigeoka, and I Nakajima, and K Nakamura, and T Hirohata, and H Jinnai, and M Yasutomi
April 2007, Transfusion medicine (Oxford, England),
K Okuno, and M Ozaki, and H Shigeoka, and I Nakajima, and K Nakamura, and T Hirohata, and H Jinnai, and M Yasutomi
March 2021, Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001),
K Okuno, and M Ozaki, and H Shigeoka, and I Nakajima, and K Nakamura, and T Hirohata, and H Jinnai, and M Yasutomi
May 2018, Journal of veterinary internal medicine,
K Okuno, and M Ozaki, and H Shigeoka, and I Nakajima, and K Nakamura, and T Hirohata, and H Jinnai, and M Yasutomi
August 2022, The Lancet. Haematology,
K Okuno, and M Ozaki, and H Shigeoka, and I Nakajima, and K Nakamura, and T Hirohata, and H Jinnai, and M Yasutomi
October 2001, Vox sanguinis,
K Okuno, and M Ozaki, and H Shigeoka, and I Nakajima, and K Nakamura, and T Hirohata, and H Jinnai, and M Yasutomi
January 2012, Archives of disease in childhood. Fetal and neonatal edition,
K Okuno, and M Ozaki, and H Shigeoka, and I Nakajima, and K Nakamura, and T Hirohata, and H Jinnai, and M Yasutomi
January 1970, Acta haematologica,
K Okuno, and M Ozaki, and H Shigeoka, and I Nakajima, and K Nakamura, and T Hirohata, and H Jinnai, and M Yasutomi
January 2014, Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001),
K Okuno, and M Ozaki, and H Shigeoka, and I Nakajima, and K Nakamura, and T Hirohata, and H Jinnai, and M Yasutomi
May 2005, Critical care medicine,
K Okuno, and M Ozaki, and H Shigeoka, and I Nakajima, and K Nakamura, and T Hirohata, and H Jinnai, and M Yasutomi
February 2016, Neurocritical care,
Copied contents to your clipboard!